Is anticipatory compounding considered manufacturing and can most pharmacies perform it?

The concept of anticipatory compounding refers to the preparation of a medication based on a prescription that is anticipated but not yet received, usually in response to known patient needs or demands. In the realm of pharmacy jurisprudence, anticipatory compounding is not considered manufacturing, as manufacturing typically involves producing drugs for wholesale distribution, which is a different regulatory framework with more stringent requirements.

Pharmacies are allowed to engage in anticipatory compounding to a certain extent, provided they adhere to applicable legal standards, which typically involve ensuring that the compounded medication is not for commercial distribution and is meant to meet individual patient needs. Most pharmacies can perform anticipatory compounding without falling under the manufacturing category, as long as they comply with state and federal regulations regarding the conditions and limits around compounding practices.

In summary, anticipatory compounding is not categorized as manufacturing, which allows most pharmacies to perform it within the legal guidelines established for compounding.